In recent years, rapid progress in the understanding and treatment of hematologic cancer has occurred, with many new and exciting treatment therapies now available to clinicians. Cancer mortality rates have begun to fall as greater and greater progress has been made in both the diagnosis and treatment of malignant disease. There has been considerable progress in our understanding of the basic biology and molecular genetics of cancer as well as the development and availability of an increasing array of novel therapies to complement traditional modalities of surgery, radiation therapy and chemotherapy. Advances in cancer treatment have been accompanied by equally impressive progress in supportive care modalities. These modalities have greatly improved the ability of oncologists to reduce the adverse impact of cancer and its treatment; furthermore, they have enabled patients to complete potentially curative treatments in an optimal fashion. Evidence-based clinical practice guidelines have emerged from a variety of professional organizations to guide clinical decisions and optimize the management of patients with malignant diseases. However, with literally hundreds of medical journals attempting to disseminate the vast amount of new medical knowledge about cancer, it has become an enormous challenge for both trainees and clinical oncologists to remain abreast of the latest and most reliable of new information to provide the best care for their patients. Therefore, a need remains for an updated and portable cancer-care resource that enables the physician to treat the patient with the best information currently available. This volume will examine all major hematologic cancers, from malignant lymphoma to multiple myeloma and acute leukemia, as well as demonstrating the the most up-to-date therapies related to all of these.